Brand Drift | MedicinMan | Arvind Nair
Brand Drift | MedicinMan | Arvind Nair
Tuesday, April 7, 2026
24.9
C
Bengaluru
Hot topics
The West Plays Precision Poker with High-stakes Specialty Drugs while India Plays Volume Chess with Portfolio Resilience
A recent industry spotlight by Venkat Mutavi notes a...
What Can Pharma Learn about Customer Experience from Other Industries?
In today's competitive retail world, lower pricing and creative...
Indian Pharma Competitor Analysis – Jan 2025
Competitor Analysis – Indian Pharma Market Jan 2025
This analysis...
Draft Pharma Policy
Get an in-depth view into the Draft Pharma Policy - MedicinMan does a deep dive with the President of Karnataka Drug and Pharmaceutical Manufacturers Association
Worldclass Healthcare But Out of Reach for Most Indians?
When an eminent cardiologist like Dr. Sunil Chandy—former Director...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
Hot topics
Zydus vs. Helsinn — What It Really Means for Indian Pharma
On December 24, 2025, the Delhi High Court delivered...
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
Sales View – On-the-Go Information, Insights & Learning for Pharma Professionals
Sudarshan Jain, Secretary General of Indian Pharmaceutical Alliance (IPA)...
IPM February 2026: Market Intelligence Report
Executive Summary
The Indian Pharmaceutical Market (IPM) sustained its growth...
Who Is Monitoring Quality in India’s Small Drug Units?
The Telangana Drugs Control Administration’s stop-use notice on a...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India
How the 2026 U.S. tariff action on branded drugs...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
From Collapse to Catalyst: Orchid Pharma’s Innovation-Led Phoenix Rise and the AMR Challenge
Opening Frame: The "Silent" Pandemic Meets Strategic Grit
In the...
Oracle Debacle – Midlife Reinvention is an Al Generated Orwellian Lie
A Tale of Two Truths: Severance, Up in the...
Sachhin Misshra has been elevated to the role of President at Akumentis Healthcare.
Sachhin Misshra has been elevated to the role of...
Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales
Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...
Newsletter
Get important news delivered directly to your inbox and stay connected!